“Anti-PD-1 Immune Checkpoint Blockade-Based Therapy Using Pembrolizumab in a Patient With High-Grade Glioblastoma”. Biomedical Research and Therapy 10, no. 5 (May 31, 2023): 5680–5685. Accessed November 15, 2024. https://preservation.bmrat.org/index.php/BMRAT/article/view/809.